Speaker Profile
Ph.D., Senior Advisor for Strategic Foresight and Innovation Office of Readiness and Response, CDC
Biography
Dr. Mauldin has extensive experience leveraging sequencing technologies to characterize novel and emerging infectious diseases. In his current position, Dr. Mauldin works to enhance public health laboratory capabilities and capacities through strategic partnerships and innovation. Recent efforts have included evaluating the utility of agnostic methods, such as metagenomic sequencing to identify pathogens in complex samples to support early warning and clinical capabilities. Dr. Mauldin leads the Office of Readiness and Responses Threat Agnostic Sentinel Surveillance (TASS) pilot, which leverages cross-sector partnerships to build metagenomic sequencing capabilities and capacities in public health laboratories. He also supports various implementation pilots exploring how these technologies may be leveraged to augment existing surveillance networks.
Session Abstract – PMWC 2025 Silicon Valley
Track Chairs:
Charles Chiu, UCSF
- PMWC 2025 Award Ceremony
Pioneer Honoree: Julie Louise Gerberding, FNIH
Luminary Honoree: Charles Chiu, UCSF
- Keynote: From Crisis to Cure: Navigating Public Health Challenges in the Era of Precision Diagnostics
- Julie Louise Gerberding, FNIH
- Keynote: Clinical Metagenomic Sequencing for Precision Diagnosis of Infectious Diseases
- Charles Chiu, UCSF
- Harnessing Emerging Diagnostic Technologies in Primary and Critical Care (PANEL)
Chair: Mylynda Massart, UPMC
- Christopher Woods, Duke
- Yvonne Maldonado, Stanford
- Chaz Langelier, UCSF - New Viral and Microbiome Associations with Cancer
Chair: Charles Chiu, UCSF
- Nancy Joseph, UCSF
- Melody Smith, Stanford
- Advancements in Clinical Metagenomics
Chair: Sivan Bercovici, Karius
- Charles Chiu, UCSF
- Robert Schlaberg, Illumina
- Catherine Hogan, BCCDC, UBC
- Metagenomics and Partnerships: Monitoring Infectious Disease Threats
Chair: Eric Delwart UCSF
- Mindy Nye, LabCorp
- Ranga Sampath, Siemens Healthineers
- Charles Chiu, UCSF - Innovative Therapeutics and Host-Pathogen Interactions in Infectious Disease Management
- Victor Nizet, UCSD
- Nevan Krogan, UCSF
